ICLR (ICLR) Stock Price & Analysis
ICLR (ICLR) rose 0.78% to USD 164.85 as of September 8, 2026 at 05:46 UTC, according to Nexqual real-time market data.
ICLR last closed at USD 164.85; the session ranged USD 159.5–165.87 on volume of 796,396 shares. Market capitalization is —, with a 52-week range of USD 66.57–203.91 (NMS). Source: Nexqual, September 8, 2026 at 05:46 UTC.
Key Statistics (as of September 8, 2026 at 05:46 UTC)
| Price | USD 164.85 |
|---|---|
| Change | ▲ 0.78% (up) |
| Previous Close | USD 164.85 |
| Open | USD 164.85 |
| Day Range | USD 159.5 – 165.87 |
| 52-Week Range | USD 66.57 – 203.91 |
| Volume | 796,396 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ICLR)
Nexqual's technical model rates ICLR "SELL" based on 1 bullish and 4 bearish signals across 128 daily candles, as of September 8, 2026 at 05:46 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 47.35 (neutral) |
| vs SMA50 | Below (USD 168) |
| MACD | -0.42 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CRL | Charles River Laboratories Inte | USD 288.5 | ▼ 1.12% |
| IQV | IQVIA Holdings, Inc. | USD 267.77 | ▲ 1.49% |
| MEDP | Medpace Holdings, Inc. | USD 591.29 | ▼ 0.29% |
| BRKR | Bruker Corporation | USD 58.5 | ▼ 0.88% |
| WST | West Pharmaceutical Services, I | USD 339.97 | ▼ 0.78% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:46 UTC. This page is informational and not investment advice.